| Price | 525.00p on 22-06-2026 at 18:35:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 550.00p |
| Sell | 500.00p |
| Last Trade: | Sell 67.00 at 500.00p |
| Day's Volume: | 435 |
| Last Close: | 525.00p |
| Open: | 525.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 525.00p - 525.00p |
| 52wk Range: | 425.00p - 1,020.00p |
| Market Capitalisation: | £81.30m |
| VWAP: | 501.33011p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 67 | 500.00p | Ordinary |
16:11:16 - 22-Jun-26 |
| Sell* | 359 | 501.00p | Ordinary |
13:33:45 - 22-Jun-26 |
| Sell* | 7 | 524.40p | Ordinary |
08:32:10 - 22-Jun-26 |
| Sell* | 2 | 524.40p | Ordinary |
08:32:08 - 22-Jun-26 |
| Sell* | 8 | 524.40p | Ordinary |
12:41:11 - 19-Jun-26 |
| Sell* | 447 | 501.00p | Ordinary |
11:43:59 - 19-Jun-26 |
| Sell* | 18 | 524.40p | Ordinary |
09:24:22 - 19-Jun-26 |
| Sell* | 1 | 524.40p | Ordinary |
08:30:23 - 19-Jun-26 |
| Buy* | 100 | 550.00p | Ordinary |
16:04:30 - 18-Jun-26 |
| Buy* | 32 | 550.00p | Ordinary |
11:26:54 - 18-Jun-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jun 2026 7:00 am | PRN | Notice of Investor Presentation |
| 15th Jun 2026 7:00 am | PRN | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board |
| 5th Jun 2026 7:00 am | PRN | Notice of Annual General Meeting |
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |
| 14th May 2026 7:00 am | PRN | Appointment of Chief Financial Officer and Board Changes |
| 11th May 2026 7:00 am | PRN | 4basebio Launches Enzymatic ssDNA Platform |
| 31st Mar 2026 7:00 am | PRN | Lease of Manufacturing Facility |
| 12th Mar 2026 7:00 am | PRN | Appointment of COO |
